Literature DB >> 5935361

Immune lysis of normal human and paroxysmal nocturnal hemoglobinuria (PNH) red blood cells. I. The sensitivity of PNH red cells to lysis by complement and specific antibody.

W F Rosse, J V Dacie.   

Abstract

Entities:  

Mesh:

Substances:

Year:  1966        PMID: 5935361      PMCID: PMC292750          DOI: 10.1172/JCI105388

Source DB:  PubMed          Journal:  J Clin Invest        ISSN: 0021-9738            Impact factor:   14.808


× No keyword cloud information.
  19 in total

1.  [Remarks on a case of Marchiafava-Micheli disease, developing for a long time under the aspect of a chronic pancytopenia].

Authors:  R ANDRE; B DREYFUS; D VERGOZ; A NAJMAN
Journal:  Presse Med       Date:  1963-03-09       Impact factor: 1.228

2.  DETERMINATION OF DENSITY DISTRIBUTION OF RED CELL POPULATION.

Authors:  D DANON; V MARIKOVSKY
Journal:  J Lab Clin Med       Date:  1964-10

3.  LIFE SPAN OF RETICULOCYTES IN PAROXYSMAL NOCTURNAL HEMOGLOBINURIA.

Authors:  S Y KAN; F H GARDNER
Journal:  Blood       Date:  1965-05       Impact factor: 22.113

4.  Paroxysmal nocturnal haemoglobinuria.

Authors:  J V DACIE
Journal:  Proc R Soc Med       Date:  1963-07

5.  Assay and properties of serum inhibitor of C'l-esterase.

Authors:  L R LEVY; I H LEPOW
Journal:  Proc Soc Exp Biol Med       Date:  1959 Aug-Sep

6.  The properdin system and immunity. IV. The hemolysis of erythrocytes from patients with paroxysmal nocturnal hemoglobinuria.

Authors:  C F HINZ; W S JORDAN; L PILLEMER
Journal:  J Clin Invest       Date:  1956-05       Impact factor: 14.808

7.  Paroxysmal nocturnal hemoglobinuria: relation of the clinical manifestations to underlying pathogenic mechanisms.

Authors:  W H CROSBY
Journal:  Blood       Date:  1953-09       Impact factor: 22.113

8.  STUDIES ON DESTRUCTION OF RED BLOOD CELLS. II. CHRONIC HEMOLYTIC ANEMIA WITH PAROXYSMAL NOCTURNAL HEMOGLOBINURIA: CERTAIN IMMUNOLOGICAL ASPECTS OF THE HEMOLYTIC MECHANISM WITH SPECIAL REFERENCE TO SERUM COMPLEMENT.

Authors:  T H Ham; J H Dingle
Journal:  J Clin Invest       Date:  1939-11       Impact factor: 14.808

9.  Immune lysis of normal human and paroxysmal nocturnal hemoglobinuria (PNH) red blood cells. II. The role of complement components in the increased sensitivity of PNH red cells to immune lysis.

Authors:  W F Rosse; J V Dacie
Journal:  J Clin Invest       Date:  1966-05       Impact factor: 14.808

10.  THE INITIATION AND ENHANCEMENT OF HUMAN RED CELL LYSIS BY ACTIVATORS OF THE FIRST COMPONENT OF COMPLEMENT AND BY FIRST COMPONENT ESTERASE; STUDIES USING NORMAL RED CELLS AND RED CELLS FROM PATIENTS WITH PAROXYSMAL NOCTURNAL HEMOGLOBINURIA.

Authors:  S YACHNIN; J M RUTHENBERG
Journal:  J Clin Invest       Date:  1965-04       Impact factor: 14.808

View more
  54 in total

1.  Murine embryonic stem cells without pig-a gene activity are competent for hematopoiesis with the PNH phenotype but not for clonal expansion.

Authors:  V Rosti; G Tremml; V Soares; P P Pandolfi; L Luzzatto; M Bessler
Journal:  J Clin Invest       Date:  1997-09-01       Impact factor: 14.808

2.  Paroxysmal nocturnal hemoglobinuria and eculizumab.

Authors:  Lucio Luzzatto; Antonio Maria Risitano; Rosario Notaro
Journal:  Haematologica       Date:  2010-04       Impact factor: 9.941

3.  Dr(a-) polymorphism of decay accelerating factor. Biochemical, functional, and molecular characterization and production of allele-specific transfectants.

Authors:  D M Lublin; E S Thompson; A M Green; C Levene; M J Telen
Journal:  J Clin Invest       Date:  1991-06       Impact factor: 14.808

Review 4.  [Paroxysmal nocturnal hemoglobinuria].

Authors:  P Blaas; S Weber; G M Hänsch; H H Peter
Journal:  Klin Wochenschr       Date:  1990-03-05

5.  The significance of erythrocyte antigen site density. II. Hemolysis.

Authors:  L W Hoyer; N C Trabold
Journal:  J Clin Invest       Date:  1971-09       Impact factor: 14.808

6.  Complement lysis of human erythrocytes. Differeing susceptibility of two types of paroxysmal nocturnal hemoglobinuria cells to C5b-9.

Authors:  C H Packman; S I Rosenfeld; D E Jenkins; P A Thiem; J P Leddy
Journal:  J Clin Invest       Date:  1979-08       Impact factor: 14.808

7.  Affected erythrocytes of patients with paroxysmal nocturnal hemoglobinuria are deficient in the complement regulatory protein, decay accelerating factor.

Authors:  A Nicholson-Weller; J P March; S I Rosenfeld; K F Austen
Journal:  Proc Natl Acad Sci U S A       Date:  1983-08       Impact factor: 11.205

8.  Presence of the Tn antigen on hematopoietic progenitors from patients with the Tn syndrome.

Authors:  W Vainchenker; G Vinci; U Testa; A Henri; A Tabilio; M P Fache; H Rochant; J P Cartron
Journal:  J Clin Invest       Date:  1985-02       Impact factor: 14.808

9.  Fixation of the first component of complement (C'la) by human antibodies.

Authors:  W F Rosse
Journal:  J Clin Invest       Date:  1969-11       Impact factor: 14.808

10.  The pathophysiology of paroxysmal nocturnal hemoglobinuria and treatment with eculizumab.

Authors:  Richard Kelly; Stephen Richards; Peter Hillmen; Anita Hill
Journal:  Ther Clin Risk Manag       Date:  2009       Impact factor: 2.423

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.